{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuralgia&page=2", "query": { "condition": "Diabetic Neuralgia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuralgia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-22T18:18:27.460Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01345045", "title": "A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathic Pain" ], "interventions": [ { "name": "ABT-639", "type": "DRUG" }, { "name": "pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 193, "start_date": "2011-04", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2013-01-08", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Anaheim, California • Long Beach, California + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01345045" }, { "nct_id": "NCT00904202", "title": "A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postherpetic Neuralgia", "Diabetic Neuropathy", "Complex Regional Pain Syndrome", "Carpal Tunnel Syndrome", "HIV Neuropathy", "Idiopathic Sensory Neuropathy", "Peripheral Neuropathy" ], "interventions": [ { "name": "Placebo Capsules + Placebo Patch", "type": "DRUG" }, { "name": "Placebo capsules + Lidoderm®", "type": "DRUG" }, { "name": "Gabapentin + Placebo", "type": "DRUG" }, { "name": "Gabapentin + Lidoderm®", "type": "DRUG" }, { "name": "Gabapentin 300 mg capsules 1800 mg/day + placebo patch", "type": "DRUG" }, { "name": "Gabapentin 1800 mg/day + Lidoderm patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endo USA Inc., a Keenova Therapeutics Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2003-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2024-01-02", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 7, "location_summary": "Birmingham, Alabama • Hueytown, Alabama • Phoenix, Arizona + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00904202" }, { "nct_id": "NCT01314222", "title": "Diabetic Peripheral Neuropathic Pain (DPNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathic Pain" ], "interventions": [ { "name": "BMS-954561", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo matching BMS-954561", "type": "DRUG" }, { "name": "Placebo matching Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 178, "start_date": "2011-03", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2015-12-07", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Lomita, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Lomita", "state": "California" }, { "city": "Los Gatos", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01314222" }, { "nct_id": "NCT01002235", "title": "Gene Therapy for Painful Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Painful Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "VM202", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Helixmith Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 12, "start_date": "2010-02", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2025-10-06", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 2, "location_summary": "Walnut Creek, California • Chicago, Illinois", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01002235" }, { "nct_id": "NCT00134524", "title": "The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Neuropathies", "Pain", "Neuralgia" ], "interventions": [ { "name": "MME procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Advanced Magnetic Research Institute International", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 100, "start_date": "2005-07", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2007-07-10", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 5, "location_summary": "Tucson, Arizona • Sterling Heights, Michigan • Mocksville, North Carolina + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Sterling Heights", "state": "Michigan" }, { "city": "Mocksville", "state": "North Carolina" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Renton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00134524" }, { "nct_id": "NCT00695565", "title": "Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Painful Diabetic Neuropathy" ], "interventions": [ { "name": "Placebo Gel", "type": "DRUG" }, { "name": "Clonidine Topical Gel (ARC-4558)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arcion Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 180, "start_date": "2008-05", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2016-11-08", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Sacramento, California • Santa Monica, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00695565" }, { "nct_id": "NCT00229437", "title": "Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathies" ], "interventions": [ { "name": "TAK-128", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 343, "start_date": "2005-03", "completion_date": "2006-05", "has_results": false, "last_update_posted_date": "2012-02-28", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 40, "location_summary": "Mesa, Arizona • Peoria, Arizona • Phoenix, Arizona + 37 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00229437" }, { "nct_id": "NCT00539175", "title": "Treatment of Painful Diabetic Neuropathy With Photon Stimulation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Neuropathy, Painful", "Diabetic Neuralgia", "Diabetic Polyneuropathy", "Diabetic Mononeuropathy" ], "interventions": [ { "name": "infrared light", "type": "DEVICE" }, { "name": "infrared light; placebo", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "East Bay Institute for Research and Education", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 120, "start_date": "2004-10", "completion_date": "2006-10", "has_results": false, "last_update_posted_date": "2007-10-04", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 1, "location_summary": "Martinez, California", "locations": [ { "city": "Martinez", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00539175" }, { "nct_id": "NCT01288937", "title": "A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Idiopathic Peripheral Neuropathy" ], "interventions": [ { "name": "Milnacipran", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 6, "start_date": "2011-04-05", "completion_date": "2014-12-23", "has_results": true, "last_update_posted_date": "2020-09-03", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01288937" }, { "nct_id": "NCT05986292", "title": "A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee", "Diabetic Neuropathic Pain", "Chronic Low-back Pain" ], "interventions": [ { "name": "LY3016859 ISA", "type": "DRUG" }, { "name": "LY3556050 ISA", "type": "DRUG" }, { "name": "LY3526318 ISA", "type": "DRUG" }, { "name": "LY3857210 ISA", "type": "DRUG" }, { "name": "Placebo Oral", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10000, "start_date": "2020-01-30", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-07-22T18:18:27.460Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 52 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05986292" } ] }